Biotech company Moderna on Wednesday announced that it has chosen Amazon Web Services as its preferred cloud partner.
The company is seen as a leader in COVID-19 vaccine research, entering its third phase of clinical trials late July.$29 billion biotech company Moderna announced a new partnership with Amazon Web Services on Wednesday that will see the cloud giant become its "preferred" cloud provider. The deal will also see Moderna tap AWS as its standard platform for doing analytics and machine learning.
"With AWS, our researchers have the ability to quickly design and execute research experiments and rapidly uncover new insights to get potentially life-saving treatments into production faster," Moderna CEO Stéphane Bancel said in that press release. Biotech giants like Moderna are increasingly modernizing their IT infrastructures in the hunt for new drugs and treatments,
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
ソース: BusinessInsider - 🏆 729. / 51 続きを読む »